Percutaneous Transluminal Angioplasty (PTA) Balloon Market Size, Share & Analysis | Global | 2025-2032 | Segmented By Device Type

Global Percutaneous Transluminal Angioplasty Balloon Market Report

The global percutaneous transluminal angioplasty balloon market was valued at $558 million in 2025. Over the forecast period, the market is expected to grow at a CAGR of 2.5% to reach nearly $663 million by 2032.

• The full report suite on the global market for percutaneous transluminal angioplasty, or PTA, balloons covers seven geographical regions: North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa. For each region, the report provides market valuation, unit analysis and average selling price data, while also extending projections through 2032 to provide a forward-looking view of market trends and performance. The structure and flow of this description follow the attached example document, adapted to the PTA balloon category and its specific market dynamics .

This report focuses on one of the most established device categories in peripheral vascular intervention. It analyzes PTA balloon catheter sales by unit volume, average selling price, procedure numbers, total market value, growth rates, market shares and forecasts through 2032, with historical data to 2022. It also includes market drivers and limiters, recent mergers and acquisitions, company profiles, product portfolios and analysis of leading competitors. Within the PTA balloon market, segmentation includes standard, high-pressure, large, small and specialty balloon catheters, along with unit analysis by application across multiple vascular territories.

Market Overview

The global PTA balloon market includes catheter-based balloons used to dilate narrowed peripheral vessels during endovascular procedures. These devices are a foundational part of peripheral vascular intervention and are used across a wide range of arterial and venous applications. In many procedures, PTA balloons are the primary treatment device. In others, they are used before or after stent placement, or alongside atherectomy, thrombectomy or other adjunctive therapies.

Because PTA balloons are used so broadly, they remain one of the most familiar product categories in the peripheral vascular space. Their role spans femoral-popliteal disease, iliac interventions, below-the-knee procedures, carotid and renal work, central venous and hemodialysis access and aortic applications. This broad clinical utility gives the category a stable procedural base, even as competition and pricing pressure intensify.

A defining feature of this market is its maturity. Standard PTA balloons are well established and are widely available from multiple competitors. In many hospitals and procedural settings, product selection in this part of the market is influenced heavily by price, vendor relationships and broader portfolio agreements. Because the basic functionality of these products is well understood, manufacturers often compete through bundling and discounting rather than through dramatic product differentiation.

Market Drivers

High Restenosis Rates

One of the main drivers of the PTA balloon catheter market is the high rate of restenosis after balloon angioplasty. Restenosis, which refers to the re-narrowing of the vascular lumen, occurs in roughly one-third of patients who undergo balloon angioplasty. This creates repeat treatment demand at the same lesion site and supports ongoing use of balloon catheters over time.

In many of these repeat cases, physicians may turn to more advanced PTA technologies in order to improve outcomes. Specialty balloons such as scoring balloons, cutting balloons and cryoplasty balloons can play a more important role when treating in-stent restenosis or more resistant lesions. Since these devices typically carry higher prices than standard balloons, repeat treatment patterns can support market value even when standard balloon ASPs remain under pressure.

Small PTA Balloon Catheters

Small PTA balloons are another important growth driver. These products allow physicians to access smaller and more difficult vascular anatomy that would not be suitable for larger standard balloons. Their usefulness in below-the-knee procedures is especially important, as these interventions often require smaller-diameter devices capable of navigating more distal lesions.

Small balloons also support a wide range of procedures beyond below-the-knee treatment. They are frequently used in tandem with other devices and are commonly employed for pre-dilation and post-dilation in procedures involving self-expanding stents, particularly in carotid and femoral-popliteal interventions. This broad utility expands their procedural relevance and supports stronger demand.

Another reason small balloons are attractive is that they can contribute to slightly shorter patient recovery times and more efficient interventions. While this is not the sole driver of product choice, it supports continued clinical use in applications where procedural control and vessel access are especially important.

Increasing POBA Procedures

The continued use of plain old balloon angioplasty, or POBA, is also helping support market demand, particularly in Europe. In some regions, vascular surgeons prefer to begin endovascular treatment with balloon deployment rather than stenting. This approach preserves future treatment options and can align with physician preference in lesion sets where permanent implants are not immediately necessary.

As a result, PTA balloons retain an important role even in markets with access to more advanced adjunctive technologies. The persistence of POBA-based treatment in certain regions helps maintain global procedure volumes and supports the overall value of the PTA balloon market.

Market Limiters

Price Erosion

The strongest limiter in the global PTA balloon market is price erosion. PTA balloons are largely commoditized products, especially in the standard segment. Because many manufacturers offer similar products, competition is intense and average selling prices remain under pressure. This is especially true when vendors use balloons as part of a larger portfolio strategy.

Companies that market higher-priced atherectomy systems or other premium vascular devices often significantly discount their balloons in order to protect or grow their share in more profitable categories. This bundling strategy allows manufacturers to maintain overall account value even if balloon margins decline. While commercially effective, it places sustained downward pressure on PTA balloon pricing across the market.

Downward pricing trends are also influenced by reimbursement restructuring and the relatively low growth potential of the standard balloon segment. Together, these factors make that portion of the market less attractive for major new investment.

Commoditization of the Standard Balloon Segment

The PTA balloon market is not limited by price alone. It is also limited by the degree of commoditization in standard balloons. In many procedural settings, standard balloons are viewed as interchangeable or near-interchangeable products. This reduces the ability of manufacturers to differentiate meaningfully on features alone and shifts competition toward contracts, pricing and supplier relationships.

As a result, the standard segment has the lowest ASP and limited room for premium positioning. Even if unit volumes remain stable, commoditization makes it harder for suppliers to drive revenue growth in the most mature part of the market.

Low Growth Potential in Mature Categories

Because standard PTA balloons are already widely used and well established, their growth potential is modest. This limits the appeal of the category for further investment compared with more differentiated vascular technologies. While procedure need remains steady, the market does not offer the same upside as faster-growing areas such as specialty lesion modification devices or more advanced imaging-guided therapy categories.

This does not mean the PTA balloon market is shrinking in relevance. It means future value growth is likely to come from smaller, high-performance and specialty products rather than from the standard segment alone.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.

Qualitative Coverage

Market drivers and limiters, growth trends, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.

Time Frame

Base year 2025, historical data to 2022 and forecasts through 2032.

Regional Coverage

North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa.

Data Types Included

Unit sales, average selling prices, procedure numbers, market size and growth trends.

This report provides a focused view of the PTA balloon market with enough detail to support pricing analysis, regional planning, application-level strategy and competitive benchmarking across the forecast period.

Markets Covered and Segmentation

• The report covers the Global Percutaneous Transluminal Angioplasty Balloon Catheter Market, further segmented into the following device types:

Standard PTA Balloons

The most mature and commoditized segment, widely used across routine vascular procedures.

High-Pressure PTA Balloons

Used where greater burst pressure is needed to treat resistant lesions or challenging anatomy.

Large PTA Balloons

Applied in larger vessels and selected high-diameter indications.

Small PTA Balloons

Used in narrower and harder-to-access vessels, including below-the-knee and other complex peripheral applications.

Specialty PTA Balloons

Includes higher-value products such as cryoplasty, cutting and scoring balloons.

The report also includes unit analysis by application across central venous and hemodialysis access, femoral-popliteal, iliac, infra-popliteal, renal, carotid, aorta and other procedures. Each segment is analyzed through market value, units and ASP, with forecasts through 2032.

Competitive Analysis

Boston Scientific is a major competitor in the global PTA balloon catheter market. The company has established offerings in the standard balloon segment through products such as the Mustang and Coyote balloon catheters. It also holds a strong position in the specialty PTA balloon segment with the Flextome Cutting Balloon Dilatation Device. Its 2018 acquisition of Cryterion Medical expanded its technology base with a single-shot cryoablation platform, reinforcing its broader intervention portfolio. This mix of standard and specialty products supports Boston Scientific's position across several balloon categories.

Becton Dickinson, or BD, remains highly influential in the high-pressure balloon segment. The Conquest high-pressure balloon has remained popular because of strong physician acceptance, and the company's intellectual property position has played an important role in this market. Patent control over high-pressure balloon technology creates a competitive advantage, especially because alternative designs from competitors may require thicker walls and higher profiles, which can reduce the low-profile characteristics physicians often prefer. BD's Atlas device is especially notable for combining a low profile with high burst pressure, while the Dorado and Conquest platforms extend the company's presence across higher-pressure use cases.

Medtronic is another leading competitor, supported by a broad portfolio that includes Admiral Xtreme, Evercross and Chocolate balloon catheters. The Chocolate balloon stands out for its nitinol cage design, which enables more controlled dilation and helps reduce dissection propagation by creating smaller dissections. Medtronic also supports its share through additional offerings such as RapidCross, Reef and Amphirion Deep balloons, giving it broad participation across several subsegments of the PTA balloon market.

Overall, competition in this market is shaped by broad portfolio coverage, physician familiarity, performance in high-pressure and specialty categories and the ability to compete in a pricing environment where standard balloons are heavily discounted.

Technology and Practice Trends

One of the clearest trends in the PTA balloon market is the ongoing commoditization of standard balloons. These products remain essential, but pricing pressure is strong and differentiation is limited.

At the same time, specialty PTA balloons continue to offer stronger value. Cutting balloons, scoring balloons and cryoplasty devices address tougher lesion types and often command higher ASPs than standard products.

Smaller-profile balloons are also becoming more important because they expand access to more difficult anatomy and support treatment in below-the-knee and other distal vascular procedures.

High-pressure balloons remain relevant in lesions where greater force is needed, and this segment continues to benefit from physician demand for devices that combine strong performance with low-profile delivery.

Across the market, practice patterns show that balloons are increasingly used as part of multi-device procedures rather than as stand-alone tools in every case. This reinforces the category's importance but also ties its commercial value to broader endovascular treatment strategy.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

87 pages of detailed market analysis, forecasts and category-level discussion.

Methodology Appendix and Acronym Glossary.

Why This Report

Where are the most attractive opportunities in the global PTA balloon market despite strong price erosion?

How are small and specialty balloons changing the value mix within this mature category?

Which applications and regions continue to support stable procedure demand through 2032?

How does commoditization affect pricing, competition and future supplier strategy?

Which companies lead in standard, high-pressure and specialty PTA balloons, and how are they positioned competitively?

How do repeat procedures, restenosis treatment and adjunctive use patterns support long-term balloon demand?

The Global Percutaneous Transluminal Angioplasty Balloon Market Report from iData Research answers these questions with detailed segmentation, pricing analysis, competitive intelligence and forecast modeling. Use it to benchmark market position, identify higher-value subsegments and support commercial planning in a mature but essential vascular device category.